Biomarker could improve prediction of response to immunotherapy in black skin cancer
If black skin cancer (melanoma) spreads, there are various therapies that can be used. However, there is still insufficient research into who responds to which therapy and whether resistance may develop over time. In a new study, Dr Simon Fietz, assistant physician at the Clinic